Merck (MRK) Other Non-Current Assets (2009 - 2026)

Merck has disclosed Other Non-Current Assets across 16 years of filings, most recently posting $19.8 billion for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 18.12% year-over-year to $19.8 billion; the TTM figure through Mar 2026 stood at $19.8 billion (up 18.12% YoY), while the FY2025 annual figure was $18.8 billion, up 17.29% from the prior year.
• Other Non-Current Assets climbed to $19.8 billion in Q1 2026, from $18.8 billion in the prior quarter.
• Over the last five years, Other Non-Current Assets for MRK reached as high as $19.8 billion in Q1 2026 and fell as low as $4.0 million in Q2 2022.
• The 5-year median for Other Non-Current Assets is $13.6 billion (2024), against an average of $12.8 billion.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets jumped 18308.7% — and 2025, when it grew 17.29%.
• A 5-year view of Other Non-Current Assets shows it stood at $9.5 billion in 2022, then rose by 25.9% to $12.0 billion in 2023, then surged by 33.74% to $16.0 billion in 2024, then gained by 17.29% to $18.8 billion in 2025, then increased by 5.25% to $19.8 billion in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $19.8 billion, $18.8 billion, and $18.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.